LatAm-FINGERS is a multicentre dementia-prevention trial that tested whether structured lifestyle coaching protects thinking skills better than general health advice. Reported in July 2026, it found that supervised exercise, diet counseling, cognitive training, and cardiovascular-risk management together produced measurably larger cognitive gains than periodic advice alone, across 12 sites in 11 Latin American countries. The trial enrolled older adults, not midlife adults, so its results answer a narrower question than the headline suggests. What it does offer midlife readers is a tested model for *how* a multidomain program works in diverse, resource-varied settings — paired with separate evidence on which risk factors matter most when started earlier in life.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What LatAm-FINGERS Actually Tested
- How Much Difference Did the Structured Program Make?
- Did the Program Hold Up in Everyday, Resource-Varied Settings?
- Why "Midlife" Still Matters, Even Though the Trial Didn't Enrol Midlife Adults
- Translating the Two Studies Into Practical Steps
What LatAm-FINGERS Actually Tested
LatAm-FINGERS was a single-blind, multicentre randomized controlled trial that followed 1,065 adults aged 60 to 77 who were already at increased dementia risk, tracking them for two years across 12 sites in 11 Latin American countries, as reported by Crivelli and colleagues in The Lancet and summarized by Healio. Participants were split into two groups. One received a structured, supervised program combining supervised exercise sessions, MIND-diet counseling, computerized cognitive training, cardiovascular-risk management, and group social activities.
The other received a flexible program of periodic health advice without the supervised structure, according to the Alzheimer's Association's press release and Medscape's coverage of the results. The trial was designed as a culturally adapted version of the U.S. POINTER trial, built within the World-Wide FINGERS research network. Investigators describe the Latin American results as reinforcing what POINTER already showed: a structured, supervised multidomain program outperforms general advice, and that pattern now holds across two different populations and healthcare settings, per Alzheimer Europe's summary.
How Much Difference Did the Structured Program Make?
The structured-program group gained 0.31 standard deviations per year on a global cognitive composite score, compared with 0.20 standard deviations per year in the flexible-advice group — a roughly 55% larger annual gain, according to Medscape's report on the trial. The benefit was not spread evenly across every mental skill. Episodic memory — the ability to recall specific recent events — showed the largest between-group difference, at 0.14 (95% CI 0.07–0.21).
Executive function and processing speed each improved by a smaller but still statistically significant 0.04 (95% CI 0.01–0.07 and 0.01–0.08, respectively), as detailed in Healio's coverage. These are test-performance gains measured over two years, not a reduction in diagnosed dementia cases. The trial was built to detect whether structured coaching changes how people perform on cognitive testing, and that is the question it answers.
Did the Program Hold Up in Everyday, Resource-Varied Settings?
A multidomain program is only useful if people can stick with it outside a research lab. Of those enrolled, 82.3% completed the full two-year follow-up, and participants in the structured arm maintained 71.6% mean adherence to the program's components, with no serious intervention-related adverse events reported, according to AAIC press materials cited by Medscape.
Those completion and safety figures matter because the 12 sites spanned 11 countries with differing healthcare infrastructure and resources. A program that only works inside a well-funded academic medical center tells you little about what's feasible for most people. LatAm-FINGERS was designed to test transportability, and the retention and safety data support the idea that supervised, multidomain coaching can run in varied settings without requiring rare or specialized resources.
Why "Midlife" Still Matters, Even Though the Trial Didn't Enrol Midlife Adults
LatAm-FINGERS enrolled adults aged 60 to 77, not people in their 40s or 50s. Its two-year results measure cognitive-test performance in that older group — they do not show that starting a similar program in midlife changes someone's eventual risk of developing dementia. That distinction matters for anyone trying to apply these findings to an earlier stage of life. The case for acting in midlife instead comes from a separate body of evidence: the 2024 Lancet Commission on Dementia Prevention, Intervention, and Care.
That analysis estimated that eliminating 14 modifiable risk factors could reduce global dementia prevalence by 45%, and it specifically flagged several as midlife-stage targets — hearing loss, high LDL cholesterol, depression, traumatic brain injury, physical inactivity, diabetes, smoking, hypertension, obesity, and excessive alcohol use, according to Alzheimer Europe's summary of the Commission's report. That 45% figure is a modelled projection, not a measured trial outcome. It assumes the listed risk factors are causal and that every one is fully eliminated across a population — an upper-bound estimate of what's theoretically possible, not a guarantee for any one person who addresses some of these factors. Reading it as a ceiling rather than a promise keeps expectations realistic while still pointing to where midlife effort has the strongest rationale.
Translating the Two Studies Into Practical Steps
Put together, the two studies point in a consistent direction without claiming the same thing. LatAm-FINGERS shows that structured, supervised, multidomain coaching outperforms generic advice for people already at risk later in life.
The Lancet Commission identifies which risk factors are worth targeting earlier, in midlife, before that higher-risk stage arrives. For someone in their 40s or 50s, that combination suggests a few concrete priorities rather than a single prescribed program: None of this reproduces LatAm-FINGERS' exact structured protocol for a midlife population — that trial hasn't been run. What midlife adults have is the Lancet Commission's risk-factor targets and a demonstrated, transportable model, from an older cohort, of how structured coaching beats generic advice when applied consistently.
- Treat hearing loss, high LDL cholesterol, depression, hypertension, diabetes, and obesity as items to manage with a clinician now, since the Lancet Commission names all of them as midlife-specific targets.
- Build routine physical activity and a diet pattern resembling the MIND-diet counseling used in LatAm-FINGERS, rather than waiting for a formal risk assessment to start.
- Favor structure and supervision over occasional advice when a choice exists — LatAm-FINGERS measured a real gap between a supervised program and periodic guidance, even if that gap was measured in an older cohort.
- Address smoking, excessive alcohol use, and head-injury risk (such as unsafe driving or high-risk sports without protective gear), all flagged in the Commission's 14-factor list.
You Might Also Like
- Evidence-Based Dementia Caregiver Programs Expanding in 2026: Questions Working Dementia Caregivers Can Ask Local Care Programs
- Evidence-Based Dementia Caregiver Programs Expanding in 2026: Care-Planning Implications for Working Dementia Caregivers
- Maine’s 2026 ECHO Training for Dementia Risk Reduction: Local Action Questions for Family Caregivers
